Cancer, genes, and catechol estrogen metabolites

International Journal of Clinical Oncology

Volumn 8, Issue 1, 2003, Pages 65-66

  Mas, Sergi ^a   Laso, Nuria ^a   Lafuente, Maria Jose ^a   Lafuente, Amalia ^a   Molina, Rafael ^b   Ballesta, Antonio ^b   Zheng, Shichun ^c   Wiencke, John Kevin ^c  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL ESTROGEN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);

CANCER GENETICS; CANCER SUSCEPTIBILITY; CARCINOGENICITY; DISEASE COURSE; ENZYME ACTIVITY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; GENOTYPE; HOMOZYGOSITY; HUMAN; LETTER; PRIORITY JOURNAL;

BREAST NEOPLASMS; CATECHOL O-METHYLTRANSFERASE; ENZYME ACTIVATION; ESTROGENS, CATECHOL; HUMANS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 0037296469     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/s101470300011     Document Type: Letter

References (1)

1. Hamajima N, Matsuo K, Tajima K, et al. (2001) Limited association between a catechol-O-methyltransferase (COMT) polymorphism and breast cancer risk in Japan. Int J Clin Oncol 6:13-18